$USNA News

USANA Health Sciences: No Clear Growth Engine Left (Rating Downgrade)

USANA Health Sciences, Inc. (USNA) Q2 2026 Earnings Call Transcript

USANA Health Sciences (NYSE:USNA) Shares Tumble as Q2 Results Miss and Guidance Slashed

Usana Health Sciences Lowers FY2026 Adj EPS Guidance from $1.95-$2.29 to $0.76 vs $2.12 Est; Lowers FY2026 Sales Guidance from $925.000M-$1.000B to $910.000M vs $945.097M Est

Usana Health Sciences Q2 Adj. EPS $(0.07) Misses $0.43 Estimate, Sales $223.273M Miss $235.003M Estimate

USANA Extends Nordiq Canada Partnership Through 2030 Winter Games

USANA Health Sciences: How The Restructuring Plan Makes It A Strong Buy

USANA Earns Dual Best of State Honors for Product Innovation and Development

Kevin Guest Encourages Professionals to Prioritize Wellness During Professional Wellness Month

Should Value Investors Buy USANA Health Sciences (USNA) Stock?

5 Revealing Analyst Questions From USANA’s Q1 Earnings Call

USNA or SDZNY: Which Is the Better Value Stock Right Now?

USANA Health (USNA) Upgraded to Buy: What Does It Mean for the Stock?

USANA Health Sciences, Inc. Just Recorded A 78% EPS Beat: Here's What Analysts Are Forecasting Next

USANA's People-First Culture Earns Spot on USA TODAY Top Workplaces List

USANA Hosts Inspiring Spa & Wellness Retreat to Empower Women Across Asia Pacific

USANA (USNA) Q1 2026 Earnings Call Transcript

USANA Health Sciences, Inc. (USNA) Q1 2026 Earnings Call Transcript

Usana Health Sciences Q1 2026 Earnings Call Transcript

USANA Health Sciences (USNA) Q1 Earnings and Revenues Surpass Estimates